• 1
    Shattil SJ. Regulation of platelet anchorage and signaling by integrin alpha IIb beta 3. Thromb Haemost 1993; 70: 2248.
  • 2
    Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 15539.
  • 3
    Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 140911.
  • 4
    Patrono C, Coller B, Dalen JE et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 2001; 119 (Suppl.): 39S63S.
  • 5
    Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 7186.
  • 6
    Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 10416.
  • 7
    Kunicki TJ, Newman PJ. The molecular immunology of human platelet proteins. Blood 1992; 80: 1386404.
  • 8
    Weiss EJ, Bray PF, Tayback M et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 10904.
  • 9
    Carter AM, Ossei-Gerning N, Wilson IJ, Grant PJ. Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 1997; 96: 142431.
  • 10
    Zotz RB, Winkelmann BR, Nauck M et al. Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 1998 79; 7315.
  • 11
    Pastinen T, Perola M, Niini P et al. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet 1998; 7: 145362.
  • 12
    Anderson JL, King GJ, Bair TL et al. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 1999; 33: 72733.
  • 13
    Ardissino D, Mannucci PM, Merlini PA et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 4651.
  • 14
    Mikkelsson J, Perola M, Laippala P et al. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 1999; 19: 25738.
  • 15
    Herrmann SM, Poirier O, Marques-Vidal P et al. The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l‘Infarctus du Myocarde. Thromb Haemost 1997; 77: 117981.
  • 16
    Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 3858.
  • 17
    Samani NJ, Lodwick D. Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res 1997; 33: 6937.
  • 18
    Corral J, Gonzalez-Conejero R, Rivera J, Iniesta JA, Lozano ML, Vicente V. HPA-1 genotype in arterial thrombosis – role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 1997; 8: 28490.
  • 19
    Gardemann A, Humme J, Stricker J et al. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 1998; 80: 2147.
  • 20
    Scaglione L, Bergerone S, Gaschino G et al. Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction. Eur J Clin Invest 1998; 28: 3858.
  • 21
    Dem Borne AE, Decary F. Nomenclature of platelet-specific antigens. Transfusion 1990; 30: 477.
  • 22
    Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion 1995; 35: 8637.
  • 23
    Odawara M, Matsunuma A, Yamashita K. Platelet glycoprotein IIIa PlA polymorphism and Japanese diabetic patients with coronary heart disease. Lancet 1996; 348: 1310.
  • 24
    de Maat MP, Bladbjerg EM, Johansen LG, Bentzen J, Jespersen J. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease. Lancet 1997; 349: 1099100.
  • 25
    Michelson AD, Furman MI, Goldschmidt-Clermont P et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000; 101: 10138.
  • 26
    Feng D, Lindpaintner K, Larson MG et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999; 19: 11427.
  • 27
    Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59: 6079.
  • 28
    Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol 1987; 126: 91221.
  • 29
    Rasmussen SL, Torp-Pedersen C, Borch-Johnsen K, Ibsen H. Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey. J Hypertens 1998; 16: 141524.
  • 30
    Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 1. The Analysis of Case-Control Studies, 1st edn. Oxford: Oxford University Press, 1980.
  • 31
    Bray PF, Weiss EJ, Tayback M, Goldschmidt-Clermont PJ. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease. Lancet 1997; 349: 11001.
  • 32
    Harvald B, Hauge M. Coronary occlusion in twins. Acta Genet Med Gemellol (Roma) 1970; 19: 24850.
  • 33
    Barakat K, Kennon S, Hitman GA et al. Interaction between smoking and the glycoprotein IIIa P1(A2) polymorphism in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 2001; 38: 163943.
  • 34
    Abbate R, Marcucci R, Camacho-Vanegas O et al. Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1998; 82: 5245.
  • 35
    Kristensen SD, Milner PC, Martin JF. Bleeding time and platelet volume in acute myocardial infarction – a 2 year follow-up study. Thromb Haemost 1988; 59: 3536.
  • 36
    Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 2000; 110: 9657.
  • 37
    Siscovick DS, Schwartz SM, Rosendaal FR, Psaty BM. Thrombosis in the young: effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors. Thromb Haemost 1997; 78: 712.
  • 38
    Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost 2001; 85: 62633.